StockDiagnosis

PFE Stock Analysis — Pfizer Inc

AI-powered earnings and news diagnosis. Updated regularly.

Company Overview

Sector
HEALTHCARE
P/E Ratio
18.45
EPS
$1.31
Profit Margin
0.118

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.

Latest AI Diagnosis

Bullish

Pfizer is building momentum with a deep research pipeline in cancer, obesity, and vaccines heading into a pivotal 2026. Recent cancer data presentations and strategic R&D investments suggest growing optimism, though results still need to prove out commercially.

Read full analysis →

Get a fresh AI diagnosis of PFE

Sign up free — 3 analyses per month included.

Analyze PFE Now